Ali Motazedian

702 total citations
12 papers, 313 citations indexed

About

Ali Motazedian is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Ali Motazedian has authored 12 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Cell Biology and 3 papers in Immunology. Recurrent topics in Ali Motazedian's work include Pluripotent Stem Cells Research (4 papers), Renal and related cancers (3 papers) and Zebrafish Biomedical Research Applications (3 papers). Ali Motazedian is often cited by papers focused on Pluripotent Stem Cells Research (4 papers), Renal and related cancers (3 papers) and Zebrafish Biomedical Research Applications (3 papers). Ali Motazedian collaborates with scholars based in Australia, Canada and Japan. Ali Motazedian's co-authors include Edouard G. Stanley, Santhosh V. Kumar, Amranul Haque, Alicia Oshlack, Alexander N. Combes, Irene M. Ghobrial, Andrew G. Elefanty, Kynan T. Lawlor, Melissa H. Little and Pei Xuan Er and has published in prestigious journals such as Nature Communications, PLoS ONE and Nature Cell Biology.

In The Last Decade

Ali Motazedian

12 papers receiving 312 citations

Peers

Ali Motazedian
Karen Dyer Montgomery United States
Hyun‐Yi Kim South Korea
Ali Motazedian
Citations per year, relative to Ali Motazedian Ali Motazedian (= 1×) peers Paula Deschamps

Countries citing papers authored by Ali Motazedian

Since Specialization
Citations

This map shows the geographic impact of Ali Motazedian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Motazedian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Motazedian more than expected).

Fields of papers citing papers by Ali Motazedian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Motazedian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Motazedian. The network helps show where Ali Motazedian may publish in the future.

Co-authorship network of co-authors of Ali Motazedian

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Motazedian. A scholar is included among the top collaborators of Ali Motazedian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Motazedian. Ali Motazedian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Sun, Shicheng, Ali Motazedian, Joe Jiang Zhu, et al.. (2024). Efficient generation of human NOTCH ligand-expressing haemogenic endothelial cells as infrastructure for in vitro haematopoiesis and lymphopoiesis. Nature Communications. 15(1). 7698–7698. 1 indexed citations
2.
Gillespie, Andrea, Ali Motazedian, Kah Lok Chan, et al.. (2023). Targeting Menin disrupts the KMT2A/B and polycomb balance to paradoxically activate bivalent genes. Nature Cell Biology. 25(2). 258–272. 19 indexed citations
3.
Motazedian, Ali, Freya Bruveris, Santhosh V. Kumar, et al.. (2020). Multipotent RAG1+ progenitors emerge directly from haemogenic endothelium in human pluripotent stem cell-derived haematopoietic organoids. Nature Cell Biology. 22(1). 60–73. 35 indexed citations
4.
Bruveris, Freya, Elizabeth Ng, Ana Rita Leitoguinho, et al.. (2020). Human yolk sac-like haematopoiesis generates RUNX1- and GFI1/1B-dependent blood and SOX17-positive endothelium. Development. 147(20). 14 indexed citations
5.
Motazedian, Ali, et al.. (2019). Generation of a heterozygous COL1A1 (c.3969_3970insT) osteogenesis imperfecta mutation human iPSC line, MCRIi001-A-1, using CRISPR/Cas9 editing. Stem Cell Research. 37. 101449–101449. 15 indexed citations
6.
Howden, Sara E., Ali Motazedian, Andrew G. Elefanty, et al.. (2019). The use of simultaneous reprogramming and gene correction to generate an osteogenesis imperfecta patient COL1A1 c. 3936 G>T iPSC line and an isogenic control iPSC line. Stem Cell Research. 38. 101453–101453. 12 indexed citations
7.
Joshi, Kriti, Colleen M. Elso, Ali Motazedian, et al.. (2019). Induced pluripotent stem cell macrophages present antigen to proinsulin-specific T cell receptors from donor-matched islet-infiltrating T cells in type 1 diabetes. Diabetologia. 62(12). 2245–2251. 17 indexed citations
8.
Kumar, Santhosh V., Pei Xuan Er, Kynan T. Lawlor, et al.. (2019). Kidney micro-organoids in suspension culture as a scalable source of human pluripotent stem cell-derived kidney cells. Development. 146(5). 109 indexed citations
9.
Cornwell, James A., Robin Hallett, Ali Motazedian, et al.. (2016). Quantifying intrinsic and extrinsic control of single-cell fates in cancer and stem/progenitor cell pedigrees with competing risks analysis. Scientific Reports. 6(1). 27100–27100. 10 indexed citations
10.
Haque, Amranul, Nihad Adnan, Ali Motazedian, et al.. (2015). An Engineered N-Cadherin Substrate for Differentiation, Survival, and Selection of Pluripotent Stem Cell-Derived Neural Progenitors. PLoS ONE. 10(8). e0135170–e0135170. 22 indexed citations
11.
Hallett, Robin, Cheng Huang, Ali Motazedian, et al.. (2015). Treatment-induced cell cycle kinetics dictate tumor response to chemotherapy. Oncotarget. 6(9). 7040–7052. 13 indexed citations
12.
Haque, Amranul, Xiaoshan Yue, Ali Motazedian, Yoh‐ichi Tagawa, & Toshihiro Akaike. (2012). Characterization and neural differentiation of mouse embryonic and induced pluripotent stem cells on cadherin-based substrata. Biomaterials. 33(20). 5094–5106. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026